Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6801570

O=C(CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccc2c(c1)CCNCC2.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 2/20 0.56
DRD2 P14416 6/20 0.50
DRD3 P35462 5/20 0.50
ADRA1A P35348 1/20 0.50
HTR7 P34969 4/20 0.48
SIGMAR1 Q99720 3/20 0.48
HTR1A P08908 2/20 0.47
HTR2A P28223 2/20 0.47
DRD4 P21917 1/20 0.47
HTR2C P28335 1/20 0.47
DRD5 P21918 1/20 0.47
DRD1 P21728 1/20 0.47
ABCB11 O95342 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
PKM P14618 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
THPO P40225 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6807449 0.86 MCHR1 (0.60) MCHR1DRD2DRD3HTR7SIGMAR1
SCHEMBL5578409 0.85 MCHR1 (0.71) MCHR1DRD2DRD3HTR7HTR1A
Hydrochloric Acid SCHEMBL5578294 0.84 MCHR1 (0.70) MCHR1DRD2DRD3HTR7HTR1A
Trifluoroacetic Acid SCHEMBL6807608 0.82 MCHR1 (0.62) MCHR1DRD2DRD3HTR7HTR1A
Trifluoroacetic Acid SCHEMBL6807470 0.82 MCHR1 (0.57) MCHR1DRD2DRD3HTR7HTR1A
Trifluoroacetic Acid SCHEMBL6802111 0.82 MCHR1 (0.64) MCHR1DRD2DRD3HTR7HTR1A
Trifluoroacetic Acid SCHEMBL6803305 0.81 MCHR1 (0.63) MCHR1DRD2DRD3HTR7SIGMAR1
Trifluoroacetic Acid SCHEMBL6799476 0.81 MCHR1 (0.60) MCHR1DRD2DRD3HTR7HTR1A
Trifluoroacetic Acid SCHEMBL6795675 0.80 MCHR1 (0.59) MCHR1DRD2DRD3HTR7HTR1A
Trifluoroacetic Acid SCHEMBL6802636 0.79 MCHR1 (0.58) MCHR1DRD2DRD3HTR7HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063699-A1 Gpr14 antagonist TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-04-01 US disclosed
EP-1310490-A1 GPR14 ANTAGONIST Takeda Chemical Industries, Ltd. (JP) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063699-A1 Gpr14 antagonist GPR142, GPR139, GPR4 MCHR1 191/4885DRD2 329/4885DRD3 433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.